Logo image of SLNH

SOLUNA HOLDINGS INC (SLNH) Stock Fundamental Analysis

NASDAQ:SLNH - Nasdaq - US5835433013 - Common Stock - Currency: USD

0.6196  -0.02 (-3.19%)

After market: 0.647 +0.03 (+4.42%)

Fundamental Rating

1

SLNH gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. SLNH has a bad profitability rating. Also its financial health evaluation is rather negative. SLNH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SLNH has reported negative net income.
SLNH had a negative operating cash flow in the past year.
SLNH had negative earnings in 4 of the past 5 years.
In multiple years SLNH reported negative operating cash flow during the last 5 years.
SLNH Yearly Net Income VS EBIT VS OCF VS FCFSLNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

SLNH has a Return On Assets of -72.89%. This is amonst the worse of the industry: SLNH underperforms 86.93% of its industry peers.
Industry RankSector Rank
ROA -72.89%
ROE N/A
ROIC N/A
ROA(3y)-73.36%
ROA(5y)-40.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SLNH Yearly ROA, ROE, ROICSLNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

SLNH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLNH Yearly Profit, Operating, Gross MarginsSLNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

More info and screens

0

2. Health

2.1 Basic Checks

SLNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
SLNH has more shares outstanding than it did 1 year ago.
SLNH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SLNH is higher compared to a year ago.
SLNH Yearly Shares OutstandingSLNH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SLNH Yearly Total Debt VS Total AssetsSLNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

SLNH has an Altman-Z score of -5.98. This is a bad value and indicates that SLNH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.98, SLNH is doing worse than 83.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.98
ROIC/WACCN/A
WACC8.32%
SLNH Yearly LT Debt VS Equity VS FCFSLNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 0.33 indicates that SLNH may have some problems paying its short term obligations.
SLNH has a worse Current ratio (0.33) than 93.64% of its industry peers.
A Quick Ratio of 0.33 indicates that SLNH may have some problems paying its short term obligations.
SLNH has a Quick ratio of 0.33. This is amonst the worse of the industry: SLNH underperforms 93.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
SLNH Yearly Current Assets VS Current LiabilitesSLNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48.49% over the past year.
The Revenue has been growing slightly by 2.85% in the past year.
SLNH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.07% yearly.
EPS 1Y (TTM)48.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.19%
Revenue 1Y (TTM)2.85%
Revenue growth 3Y38.37%
Revenue growth 5Y42.07%
Sales Q2Q%-52.7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLNH Yearly Revenue VS EstimatesSLNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLNH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLNH Price Earnings VS Forward Price EarningsSLNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLNH Per share dataSLNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLNH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOLUNA HOLDINGS INC

NASDAQ:SLNH (6/2/2025, 8:00:02 PM)

After market: 0.647 +0.03 (+4.42%)

0.6196

-0.02 (-3.19%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-16 2025-05-16
Earnings (Next)N/A N/A
Inst Owners10.45%
Inst Owner Change61.81%
Ins Owners19.93%
Ins Owner Change-0.49%
Market Cap11.59M
Analysts0
Price TargetN/A
Short Float %8.59%
Short Ratio1.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS1.68
BVpS-0.86
TBVpS-1.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -72.89%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-73.36%
ROA(5y)-40.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 80.5%
Cap/Sales 39.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -5.98
F-Score2
WACC8.32%
ROIC/WACCN/A
Cap/Depr(3y)126.88%
Cap/Depr(5y)534.63%
Cap/Sales(3y)102.76%
Cap/Sales(5y)154.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.85%
Revenue growth 3Y38.37%
Revenue growth 5Y42.07%
Sales Q2Q%-52.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-114.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.03%
OCF growth 3YN/A
OCF growth 5YN/A